Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Book Review
Case Report
Clinical Images
Clinical Images/Spotters
Current Issue
Editorial
Editorial Commentary
Images (Radiology/Radioisotope Scans/Fluoroscopy Images, etc.)
Invited Review
Mini Review
Obituary
Original Article
Ped-Endo-Journal Scan
Pediatric Endocrine Trainees Section (Open-Forum)
President’s page
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Book Review
Case Report
Clinical Images
Clinical Images/Spotters
Current Issue
Editorial
Editorial Commentary
Images (Radiology/Radioisotope Scans/Fluoroscopy Images, etc.)
Invited Review
Mini Review
Obituary
Original Article
Ped-Endo-Journal Scan
Pediatric Endocrine Trainees Section (Open-Forum)
President’s page
The Journal of Pediatric Endocrinology and Diabetes (JPED) is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Pediatric Endocrinology, Metabolism and Diabetes. The journal is owned by the  Indian Society for Pediatric and Adolescent Endocrinology (ISPAE), India and published by the Scientific Scholar.

Aims & Scope

The official journal of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) aims to promote greater knowledge, research, education and clinical practice of Pediatric Endocrinology, Metabolism and Diabetes, especially as relevant to India. A pediatric endocrinology specialty journal from our part of the world aims to provide an impetus to the objectives of promoting knowledge, research and education among pediatricians, young pediatric endocrinologists, and allied healthcare professionals related to this field.

Audience

Our audience includes practitioners from the field of Pediatric and Adolescent Endocrinology from India, the neighboring countries, and around the world.

Review Process

JPED has a highly rigorous peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel, and important. Authors disclose all conflicts, affiliations, and financial associations such that the published content is not biased.

Editorial Team

The editorial board comprises a panel of national and international experts in the field of pediatric endocrinology and allied sciences to provide their expertise and guidance in maintaining the clarity of content and focus of the purpose for the journal.

About the Editor

PSN MENON
Editor-in-Chief
Prof. PSN Menon
Consultant & Head,
Department of Pediatrics,
Jaber Al-Ahmed Armed Forces Hospital, Kuwait
Emaileditor@ispae-jped.compsnmenon@hotmail.com

Facts About the Journal

It is a peer-reviewed international journal with a double-blind review process. It publishes the article once it is accepted after double-blinded peer review. The frequency of the publication is 3 issues/year, to begin with. The first issue of the journal will be published in August 2021. Currently, we only have E-Journal and do not publish in print. The copies will be printed only on request.

Benefits

An article published in the journal can be viewed without a fee by readers all over the world. The author also gets to retain copyright to the article and the figures. This allows authors to extend their exposure in the world of medical research and get worldwide recognition for their work.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:

Google Scholar, ProQuest, ReadCube, CrossRef, Portico, EBSCO

Journal Ethics

The Journal of Pediatric Endocrinology and Diabetes is committed to meeting and upholding the standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit our Ethical Guidelines section

Plagiarism Policy

The journal uses plagiarism check software (iThenticate) on the Editor’s and Reviewer’s panel in the manuscript management system which is used to check and control Plagiarism for each article under a double-blinded peer review process. Any manuscript, that is found to have plagiarism is rejected.

Archival Policy

We use PORTICO for our third-party repository for all articles published with us. All our articles are assigned a DOI number. We are members of https://crossref.org

Open Access Publication and Creative Commons Licensing

Journal of Pediatric Endocrinology and Diabetes is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Ahead of Print Policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Journal of Pediatric Endocrinology and Diabetes has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

Subscription Information

To subscribe to this journal, please log on to https://scientificscholar.com/buy-subscriptions.

Publisher

Scientific Scholar LLC (scientificscholar.com) is a well-respected medical publisher that fully supports open access publishing models, Subscription and Society based journal models through its own in-house peer-review management system – EditorialAssist (journalmanagement.org). The head office of Scientific Scholar is in Rochester, NY, USA and has a subsidiary arm in India.

The mission of the Scientific Scholar is “Share, Learn and Improve”.